Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 2
2010 1
2011 1
2013 2
2014 3
2015 1
2016 1
2019 2
2020 4
2021 4
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Among authors: holderried taw. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
ROCKing Chronic Graft-Versus-Host Disease.
Heine A, Holderried TAW, Wolf D. Heine A, et al. Among authors: holderried taw. J Clin Oncol. 2021 Oct 10;39(29):3308. doi: 10.1200/JCO.21.01081. Epub 2021 Aug 4. J Clin Oncol. 2021. PMID: 34347530 No abstract available.
The Role of Immune Checkpoints after Cellular Therapy.
Schmitz F, Wolf D, Holderried TAW. Schmitz F, et al. Among authors: holderried taw. Int J Mol Sci. 2020 May 21;21(10):3650. doi: 10.3390/ijms21103650. Int J Mol Sci. 2020. PMID: 32455836 Free PMC article. Review.
Immunotherapy in renal cell carcinoma.
Heine A, Holderried TA, Brossart P. Heine A, et al. Among authors: holderried ta. Immunotherapy. 2009 Jan;1(1):97-107. doi: 10.2217/1750743X.1.1.97. Immunotherapy. 2009. PMID: 20635977 Review.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Reinhardt HC, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BT, Gavriilaki E, Martinez C, Chiusolo P, Mico MC, Dagunet E, Wichert S, Ozdogu H, Piekarska A, Kinsella F, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: holderried taw. Bone Marrow Transplant. 2024 Mar;59(3):380-386. doi: 10.1038/s41409-023-02174-2. Epub 2024 Jan 6. Bone Marrow Transplant. 2024. PMID: 38184740 Free PMC article.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Mai EK, Goldschmid H, Miah K, Bertsch U, Besemer B, Hänel M, Krzykalla J, Fenk R, Schlenzka J, Munder M, Dürig J, Blau IW, Huhn S, Hose D, Jauch A, Kunz C, Mann C, Weinhold N, Scheid C, Schroers R, von Metzler I, Schieferdecker A, Thomalla J, Reimer P, Mahlberg R, Graeven U, Kremers S, Martens UM, Kunz C, Hensel M, Benner A, Seidel-Glätzer A, Weisel KC, Raab MS, Salwender HJ; German-speaking Myeloma Multicenter Group (GMMG) HD6 investigators. Mai EK, et al. Lancet Haematol. 2024 Feb;11(2):e101-e113. doi: 10.1016/S2352-3026(23)00366-6. Lancet Haematol. 2024. PMID: 38302221 Free article. Clinical Trial.
NK Cells Regulate CD8+ T Cell Mediated Autoimmunity.
Lang PA, Crome SQ, Xu HC, Lang KS, Chapatte L, Deenick EK, Grusdat M, Pandyra AA, Pozdeev VI, Wang R, Holderried TAW, Cantor H, Diefenbach A, Elford AR, McIlwain DR, Recher M, Häussinger D, Mak TW, Ohashi PS. Lang PA, et al. Among authors: holderried taw. Front Cell Infect Microbiol. 2020 Feb 13;10:36. doi: 10.3389/fcimb.2020.00036. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32117809 Free PMC article.
26 results